Pulse NanoMED System for Acute Ischemic Stroke
This study is testing a new device called the Pulse NanoMED System for people who have had an acute ischemic stroke (a stroke caused by a blood clot). You might be able to join if you are between 18 and 85 years old, have had a mechanical thrombectomy (a procedure to remove a blood clot), received clot-busting medication (intravenous thrombolytics), and still have a visible clot in certain brain arteries. The study aims to see if the Pulse NanoMED procedure, used after other treatments, can improve blood flow to the brain. Researchers will check your progress at 24 hours, 7 days (or when you leave the hospital), 30 days, and 90 days after the procedure. The current status of this study is unclear, and it plans to enroll at least 15 participants.
- Study design
- This is an early feasibility study, meaning it's one of the first steps to see if the treatment is safe and works. It's a single-arm study, which means all participants will receive the Pulse NanoMED procedure.
- What's involved
- You would receive the Pulse NanoMED procedure after other stroke treatments. Your health will be checked at 24 hours, 7 days (or discharge), 30 days, and 90 days after the procedure.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 90 days after the procedure to assess their progress.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
At a glance
Conditions
NCT06052969
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of South Carolina - Prisma
Columbia, South Carolinastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Primary Objective24 hours, 7 days (or discharge, if earlier), 30 days, and 90 days post-procedure
To test the safety and feasibility of the Pulse NanoMED System in ischemic stroke patients. The potential clinical benefit of early recanalization will be visually assessed by a core laboratory by comparing baseline DSA, CTA, or MRA images with images taken at set timepoints.